A role for eosinophils in transplant rejection

Trends in Immunology

Volumn 22, Issue 5, 2001, Pages 247-251

  Goldman, Michel ^a   Moine, Alain Le ^a   Braun, Michel ^a   Flamand, Véronique ^a   Abramowicz, Daniel ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; VASCULAR CELL ADHESION MOLECULE 1;

ALLOIMMUNITY; EFFECTOR CELL; EOSINOPHIL; GRAFT REJECTION; HEART GRAFT; IMMUNE RESPONSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PATHOLOGY; REVIEW; SKIN ALLOGRAFT; T LYMPHOCYTE; TH2 CELL; XENOGRAFT;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; EOSINOPHILIA; EOSINOPHILS; GRAFT REJECTION; INTERLEUKIN-4; INTERLEUKIN-5; INTERLEUKIN-9; MICE; TH2 CELLS;

EID: 0034919643     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(01)01893-2     Document Type: Review

References (36)

1. + cells are essential for allorejection
2. + T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection
3. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity
4. Transfusion of polarized Th2-like cell populations into SCID mouse cardiac allograft recipients results in acute allograft rejection
5. + T cells or B cells
6. + T cells
7. Heterogeneity of T cell clones specific for a single indirect alloantigenic epitope (I-Ab/H-2Kd54-68) that mediate transplant rejection
8. Interleukin-5, eosinophils, and disease
9. Eosinophils and eosinophil-associated cytokines in allergic inflammation
10. Interleukin-5 deficiency abolishes eosinophilia, airways hyperreactivity and lung damage in a mouse asthma model
11. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice
12. Eosinophils are not required for the rejection of neovascularized fetal pig proislet xenografts in mice
13. + T cells, interleukin-5 and eosinophils promote the rejection of MHC class I- and II-disparate vascularized cardiac allograft
14. IL-5 mediates eosinophilic rejection of MHC class II-disparate skin allografts in mice
15. The biology of the eosinophilic leukocyte
16. Requirement for IL-13 independently of IL-4 in experimental asthma
17. Interleukin-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: Association with expression of VCAM-1
18. Murine eotaxin: An eosinophil chemoattractant inducible in endothelial cells and in interleukin-4-induced tumor suppression
19. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo
20. IL-9 induces chemokine expression in lung epithelial cells and baseline airway eosinophilia in transgenic mice
21. Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils
22. Role of common cytokine receptor gamma chain- and Jak3-dependent signaling in the proliferation and survival of murine mast cells
23. Immunological interactions between human eosinophils and cardiac mast cells
24. Interleukin 5 synthesis by eosinophils: Association with granules and immunoglobulin-dependent secretion
25. Roles of mast cells and basophils in innate and acquired immunity
26. + T cell activation
27. Suppression of immune responses by CD8 cells. II. Qa-1 on activated B cells stimulates CD8 cell suppression of T helper 2 responses
28. Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity
29. Chronic allograft nephropathy: An update
30. Critical roles for IL-4, IL-5 and eosinophils in chronic skin allograft rejection
31. Upregulation and activation of Stat6 precede vascular smooth muscle cell proliferation in carotid artery injury model
32. + T cells
33. Role of the eosinophil in chronic vascular rejection of renal allografts
34. Evidence for a nonclassical pathway of graft rejection involving interleukin 5 and eosinophils
35. Graft eosinophilia in lung transplantation
36. Randomized trial of blood eosinophil count monitoring as a guide to corticosteroid dosage adjustment after heart transplantation